Fig 3.
Relationship between lersivirine plasma concentration following a single 2,400-mg supratherapeutic dose and the time-matched placebo-adjusted mean difference (90% CI) in lersivirine QTcF.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.